Leadership

Our proven executive team brings deep, diverse cell therapy experience and is committed to developing safe, effective, and accessible NK cell therapies to patients. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Fred Aslan, M.D.
Fred Aslan, M.D.
President and Chief Executive Officer
View Bio »
Jennifer Bush
Jennifer Bush
EVP, Chief Legal & People Officer
View Bio »
Peter Flynn, Ph.D.
Peter Flynn, Ph.D.
Cofounder, Strategic Advisor
View Bio »
Thorsten Graef, M.D., Ph.D.
Thorsten Graef, M.D., Ph.D.
Chief Medical Officer
View Bio »
Christopher Horan
Christopher Horan
Chief Technical Operations Officer
View Bio »
Eugene Helsel
Eugene Helsel
Vice President, Regulatory Affairs & Quality
View Bio »
John Lim, Pharm.D.
John Lim, Pharm.D.
Vice President, Clinical Operations
View Bio »
Heather Raymon, Ph.D.
Heather Raymon, Ph.D.
SVP, Research & Early Development
View Bio »